Narcolepsy Treatment Articles & Analysis
3 news found
Citrine’s lead product candidate, Wakix® (pitolisant), is an investigational oral drug in development for the treatment of narcolepsy and obstructive sleep apnea in China. Citrine has initiated an Investigational New Drug (IND) submission for pitolisant in the treatment of narcolepsy and completed the IND submission in ...
This digital effort will help more patients obtain timely diagnosis and appropriate treatment and services. At the signing of the strategic collaboration between RareStone and Tencent,Yiou Wang,Chairman of the Beijing Pain Challenge Charity Foundation,a patient organization,which has served rare disease patients for 12 years,commented on the topic of rare disease,stating ...
In addition to developing and marketing rare disease drugs, Citrine aims to establish a patient-centric platform which educates people on rare diseases, trains doctors on diagnosis and treatment, and helps doctors develop a full disease management protocol. Citrine's lead product candidate, Wakix® (pitolisant), is an investigational oral drug in development for the ...